Ukusetyenziswa Okucetywayo
Yeyokubhaqwa ngokukhawuleza nangokufanelekileyo kwe-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG/IgM antibody kwigazi elipheleleyo lomntu, i-serum okanye i-plasma sample. Olu vavanyo luza kusetyenziswa njengoncedo ekuxilongweni kwesifo sosulelo lwe-coronavirus, esibangelwa yi-SARS-CoV-2. Olu vavanyo lubonelela ngeziphumo zovavanyo lokuqala. Iziphumo ezingalunganga azithinteli usulelo lwe-SARS-CoV-2 kwaye azinakusetyenziswa njengesiseko sonyango okanye esinye isigqibo solawulo. Ukusetyenziswa kokuxilongwa kwi-vitro kuphela.
Umgaqo woVavanyo
Isekelwe kumgaqo wovavanyo lwe-immunoassay yokubamba ukuze kufunyanwe ii-antibodies ze-COVID-19 IgG/IgM kwigazi elipheleleyo lomntu, kwi-serum nakwi-plasma. Xa isampuli yongezwa kwisixhobo sovavanyo, isampuli iya kufakwa kwisixhobo ngesenzo se-capillary, ixutywe ne-SARS-CoV-2 recombinant antigen-color latex conjugate ize idlule kwi-membrane egqunywe ngaphambili.
| Icandelo le-REF REF | B001C-01 | B001C-25 |
| Ikhasethi yovavanyo | Uvavanyo olu-1 | Uvavanyo oluyi-25 |
| Iyalahlwa | Isiqwenga esi-1 | 25 ii-pcs |
| Isisombululo seLysis yeSampuli | Ityhubhu e-1 | Iityhubhu ezingama-25 |
| Imiyalelo Yokusetyenziswa | Isiqwenga esi-1 | Isiqwenga esi-1 |
| Isatifikethi sokuThotyelwa kweMithetho | Isiqwenga esi-1 | Isiqwenga esi-1 |
Ukuba i-reagent igcinwe efrijini kwi-4-8℃, susa ikhadi le-reagent uze uyibeke kubushushu begumbi ngaphezulu kwemizuzu engama-30.
1. Vula ibhegi yefoyile ye-aluminium yekhadi lokuhlola. Susa ikhadi lovavanyo uze ulibeke ngokuthe tye etafileni.
2. Sebenzisa i-pipette ukufutha isampuli (i-serum, i-plasma okanye igazi elipheleleyo) uze wongeze i-10μL kumngxuma wesampuli wekhadi lovavanyo, uze wongeze isisombululo sokuxuba isampuli se-60μL ngoko nangoko. Qala ukubala.
Emva kwemizuzu eli-15, funda iziphumo ngokubona. (Qaphela: UNGAZIFUNDI iziphumo emva kwemizuzu engama-20!)
1.Iziphumo ezingalunganga
Ukuba kuvela umgca wokulawula umgangatho u-C kuphela kwaye imigca yokufumanisa u-G no-M ayibonakali, oko kuthetha ukuba akukho antibody entsha ye-coronavirus efunyenweyo kwaye isiphumo siba sibi.
2. Isiphumo Esihle
2.1 Ukuba zombini umgca wokulawula umgangatho C kunye nomgca wokufumanisa uM ziyavela, oko kuthetha ukuba i-antibody entsha ye-coronavirus IgM ifunyenwe, kwaye iziphumo zingqina ukuba i-antibody ye-IgM iyafumaneka.
2.2 Ukuba zombini umgca wokulawula umgangatho C kunye nomgca wokufumanisa uG ziyavela, oko kuthetha ukuba i-antibody entsha ye-coronavirus IgG ifunyenwe kwaye iziphumo zingqina ukuba i-antibody ye-IgG iyafumaneka.
2.3 Ukuba zombini umgca wokulawula umgangatho C kunye nemigca yokufumanisa uG kunye no-M ziyavela, oko kuthetha ukuba ii-antibodies ezintsha ze-coronavirus IgG kunye ne-IgM ziyafunyanwa, kwaye iziphumo ziyabonisa ukuba zombini ii-antibodies ze-IgG kunye ne-IgM ziyafumaneka.
3. Isiphumo Esingasebenziyo
Ukuba umgca wolawulo lomgangatho C awunakubonwa, iziphumo aziyi kuba zezokusebenza nokuba umgca wovavanyo uvela na, kwaye uvavanyo kufuneka luphindwe.
| Igama lemveliso | Ikati. Hayi | Ubungakanani | Isampuli | Beka ubomi kwishelufa | Ubushushu beTrans. kunye neSto. |
| (COVID-19) Ikhithi yovavanyo lwe-IgM/IgG Antibody Rapid (iLatex Chromatography) | B001C-01 | Uvavanyo olu-1/ikhithi | I-Serum/iPlasma/iGazi elipheleleyo | Iinyanga ezili-18 | 2-30℃ / 36-86℉ |
| B001C-01 | Uvavanyo lwe-25/ikhithi |